Investor Relations

Corporate Profile

Avenue Therapeutics is a specialty pharmaceutical company whose mission is to develop IV tramadol, a potential alternative that could reduce the use of conventional opioids, for patients suffering from acute pain in the U.S. Avenue is headquartered in New York City and was founded by Fortress Biotech, Inc. (NASDAQ: FBIO).

 

Press Releases

Latest Presentation

Check back later.

Recent Events

Latest Financials

Annual Report